ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

URGN UroGen Pharma Ltd

14,30
0,04 (0,28%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
UroGen Pharma Ltd URGN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,04 0,28% 14,30 20:22:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
14,50 14,14 14,70 14,30 14,26
mais cotações »

Notícias Recentes

Data Hora Fonte Título
04/05/202416:20BWUroGen Announces Results from ATLAS Showing Robust UGN-102..
04/05/202412:50BWNew Real-World Study on Retrograde Instillation of JELMYTO®..
03/05/202409:00BWUroGen Pharma to Report 2024 First Quarter Financial Results..
17/04/202413:02BWUroGen Announces New Data Presentations at the American..
15/04/202409:00BWUroGen Announces FDA Acceptance of Investigational New Drug..
03/04/202409:00BWUroGen Pharma Files Patent Infringement Action Against Teva..
14/03/202409:00BWUroGen Pharma Delivers Double Digit JELMYTO® Growth and..
08/03/202410:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
04/03/202410:00BWUroGen Pharma to Report Fourth Quarter and Full-Year 2023..
26/02/202410:00BWUroGen Pharma to Present at TD Cowen 44th Annual Health Care..
01/02/202410:00BWUroGen Pharma to Participate at Upcoming Investor..
24/01/202410:00BWUroGen Initiates Submission of a Rolling NDA to the FDA for..
17/01/202410:00BWUroGen Secures Exclusive License from medac GmbH to Develop..
11/01/202410:00BWUroGen Pharma to Participate in the B. Riley Healthcare..
08/12/202318:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
14/11/202310:00BWUroGen Pharma Reports Third Quarter 2023 Financial Results
13/11/202310:00BWUroGen will Present Scientific Advances in Bladder Cancer at..
07/11/202310:00BWUroGen Pharma to Report Third Quarter 2023 Financial Results..
03/10/202309:00BWFollowing Pre-NDA Meeting with the FDA, UroGen Announces..
11/09/202308:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
08/09/202309:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
31/08/202309:00BWUroGen Pharma to Present at Upcoming Investor Conferences
10/08/202309:00BWUroGen Pharma Reports Record JELMYTO Quarterly Sales and..
08/08/202309:00BWThe Journal of Urology Publishes Peer-Reviewed Article..
02/08/202318:00BWUroGen Pharma to Report Second Quarter 2023 Financial..
31/07/202309:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
27/07/202313:06DJNUroGen Stock Up 49% on Full Enrollment for Bladder Cancer..
27/07/202310:55BWUroGen Announces $120 Million Private Placement of Ordinary..
27/07/202310:50BWUGN-102, in Development as the Potential First Non-Surgical..
25/07/202317:10BWUroGen Pharma Announces the Appointment of James Robinson to..
10/07/202309:00BWRetrospective Study Finds JELMYTO® Use Effective Following..
06/07/202309:00BWUroGen Pharma to Host UGN-102 Data Event on July 27, 2023
20/06/202309:00BWRetrospective Study Reveals Lower Stricture Rate and..
09/06/202309:00BWUroGen Pharma Announces Inducement Grant Under Nasdaq..
02/06/202309:00BWUroGen Pharma to Present at Upcoming Investor Conferences
11/05/202309:00BWUroGen Pharma Meets Revenue Goal, Reports First Quarter 2023..

Seu Histórico Recente

Delayed Upgrade Clock